Skip to main content

Navigation group

Type at least 3 characters

5 articles

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Case Report

Accepted on 28 Oct 2024

A case report:Interstitial pneumonia following treatment of gastric cancer with Sintilimab in combination with S-1

in Respiratory Drug Safety

Pei Zhu
Qingming Sun
Sheng Xu
Wanhui Dong

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2024.1508558

Editorial

Published on 05 Feb 2024

Editorial: Treatment of comorbidities of asthma and its safety

in Respiratory Drug Safety

Serghei Covantsev
Alexandru Corlateanu

Editorial: Treatment of comorbidities of asthma and its safety

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2024.1366847

730 views

Review

Published on 14 Dec 2023

Safety of corticosteroid therapy in sarcoidosis treatment

in Respiratory Drug Safety

Alessandro Di Marco Berardino
Federico Mei
Lina Zuccatosta

Safety of corticosteroid therapy in sarcoidosis treatment

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1319931

902 views

Review

Published on 07 Nov 2023

Promising treatment biomarkers in asthma

in Respiratory Drug Safety

Barbara Bonnesen
Jens-Ulrik S. Jensen
Alexander G. Mathioudakis
Alexandru Corlateanu
Pradeesh Sivapalan

Promising treatment biomarkers in asthma

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1291471

1,474 views
1 citation

Specialty Grand Challenge

Published on 29 Oct 2021

Moving to a Personalized Approach in Respiratory Medicine. From Academic Research to Regulatory Intervention

in Respiratory Drug Safety

Mario Cazzola

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2021.752581

1,794 views
3 citations